| Catalog: | C-FC-2740A | 
| Product Type: | FCM Antibody | 
| Size: | 50 μg/100 μg | 
| Reactivity: | Mouse | 
| Analysis mode: | FCM, WB, IHC, IF | 
| Host: | Rat | 
| Isotype: | Rat IgG2a, κ | 
| Alternate names: | PD-1, Programmed Death-1 | 
| Form: | Liquid | 
| Shipping: | Biological ice pack at 4℃ | 
| Storage: | 2-8℃ | 
| Conjugation: | Unconjugated | 
| Buffer: | PBS with 0.05% Proclin300 | 
| Swiss port: | Q02242 | 
| Clone NO.: | 29F.1A12 | 
| Recommended use: | Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 μg per 106 cells in 100 μL volume or 100 μL of whole blood. It is recommended that the reagent be titrated for optimal performance for each application. | 
CD279, also known as programmed death-1 (PD-1), is a 50-55 kD glycoprotein belonging to the CD28 family of the Ig superfamily. PD-1 is expressed on activated splenic T and B cells and thymocytes. It is induced on activated myeloid cells as well. PD-1 is involved in lymphocyte clonal selection and peripheral tolerance through binding its ligands, B7-H1 (PD-L1) and B7-DC (PD-L2). It has been reported that PD-1 and PD-L1 interactions are critical to positive selection and play a role in shaping the T cell repertoire. PD-L1 negative costimulation is essential for prolonged survival of intratesticular islet allografts.
Copyright © 2025 Creative Biogene. All rights reserved.